BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 24970022)

  • 1. Attenuated ability of BACE1 to cleave the amyloid precursor protein via silencing long noncoding RNA BACE1‑AS expression.
    Liu T; Huang Y; Chen J; Chi H; Yu Z; Wang J; Chen C
    Mol Med Rep; 2014 Sep; 10(3):1275-81. PubMed ID: 24970022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silencing of long noncoding RNA XIST attenuated Alzheimer's disease-related BACE1 alteration through miR-124.
    Yue D; Guanqun G; Jingxin L; Sen S; Shuang L; Yan S; Minxue Z; Ping Y; Chong L; Zhuobo Z; Yafen W
    Cell Biol Int; 2020 Feb; 44(2):630-636. PubMed ID: 31743528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of beta-secretase.
    Faghihi MA; Modarresi F; Khalil AM; Wood DE; Sahagan BG; Morgan TE; Finch CE; St Laurent G; Kenny PJ; Wahlestedt C
    Nat Med; 2008 Jul; 14(7):723-30. PubMed ID: 18587408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative Selection of β-Site APP-Cleaving Enzyme 1 (BACE1) Cleavage Sites in Amyloid β-Protein Precursor (APP) Harboring Protective and Pathogenic Mutations within the Aβ Sequence.
    Kimura A; Hata S; Suzuki T
    J Biol Chem; 2016 Nov; 291(46):24041-24053. PubMed ID: 27687728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ginsenoside Rg1 attenuates β-amyloid generation via suppressing PPARγ-regulated BACE1 activity in N2a-APP695 cells.
    Chen LM; Lin ZY; Zhu YG; Lin N; Zhang J; Pan XD; Chen XC
    Eur J Pharmacol; 2012 Jan; 675(1-3):15-21. PubMed ID: 22166376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HuD regulates coding and noncoding RNA to induce APP→Aβ processing.
    Kang MJ; Abdelmohsen K; Hutchison ER; Mitchell SJ; Grammatikakis I; Guo R; Noh JH; Martindale JL; Yang X; Lee EK; Faghihi MA; Wahlestedt C; Troncoso JC; Pletnikova O; Perrone-Bizzozero N; Resnick SM; de Cabo R; Mattson MP; Gorospe M
    Cell Rep; 2014 Jun; 7(5):1401-1409. PubMed ID: 24857657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BACE1-AS prevents BACE1 mRNA degradation through the sequestration of BACE1-targeting miRNAs.
    Zeng T; Ni H; Yu Y; Zhang M; Wu M; Wang Q; Wang L; Xu S; Xu Z; Xu C; Xiong J; Jiang J; Luo Y; Wang Y; Liu H
    J Chem Neuroanat; 2019 Jul; 98():87-96. PubMed ID: 30959172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of BACE1-AS on β-amyloid generation by regulating BACE1 mRNA expression.
    Li F; Wang Y; Yang H; Xu Y; Zhou X; Zhang X; Xie Z; Bi J
    BMC Mol Biol; 2019 Oct; 20(1):23. PubMed ID: 31570097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased BACE1-AS long noncoding RNA and β-amyloid levels in heart failure.
    Greco S; Zaccagnini G; Fuschi P; Voellenkle C; Carrara M; Sadeghi I; Bearzi C; Maimone B; Castelvecchio S; Stellos K; Gaetano C; Menicanti L; Martelli F
    Cardiovasc Res; 2017 Apr; 113(5):453-463. PubMed ID: 28158647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SEPT8 modulates β-amyloidogenic processing of APP by affecting the sorting and accumulation of BACE1.
    Kurkinen KM; Marttinen M; Turner L; Natunen T; Mäkinen P; Haapalinna F; Sarajärvi T; Gabbouj S; Kurki M; Paananen J; Koivisto AM; Rauramaa T; Leinonen V; Tanila H; Soininen H; Lucas FR; Haapasalo A; Hiltunen M
    J Cell Sci; 2016 Jun; 129(11):2224-38. PubMed ID: 27084579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effects of β-asarone on lncRNA BACE1-mediated induction of autophagy in a model of Alzheimer's disease.
    Wang Z; Zhou J; Zhang B; Xu Z; Wang H; Sun Q; Wang N
    Behav Brain Res; 2024 Apr; 463():114896. PubMed ID: 38316166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
    Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
    Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid-β protein (Aβ) Glu11 is the major β-secretase site of β-site amyloid-β precursor protein-cleaving enzyme 1(BACE1), and shifting the cleavage site to Aβ Asp1 contributes to Alzheimer pathogenesis.
    Deng Y; Wang Z; Wang R; Zhang X; Zhang S; Wu Y; Staufenbiel M; Cai F; Song W
    Eur J Neurosci; 2013 Jun; 37(12):1962-9. PubMed ID: 23773065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-384 regulates both amyloid precursor protein and β-secretase expression and is a potential biomarker for Alzheimer's disease.
    Liu CG; Wang JL; Li L; Wang PC
    Int J Mol Med; 2014 Jul; 34(1):160-6. PubMed ID: 24827165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BACE1 elevation is involved in amyloid plaque development in the triple transgenic model of Alzheimer's disease: differential Aβ antibody labeling of early-onset axon terminal pathology.
    Cai Y; Zhang XM; Macklin LN; Cai H; Luo XG; Oddo S; Laferla FM; Struble RG; Rose GM; Patrylo PR; Yan XX
    Neurotox Res; 2012 Feb; 21(2):160-74. PubMed ID: 21725719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-340 Reduces the Accumulation of Amyloid-β Through Targeting BACE1 (β-site Amyloid Precursor Protein Cleaving Enzyme 1) in Alzheimer's Disease.
    Tan X; Luo Y; Pi D; Xia L; Li Z; Tu Q
    Curr Neurovasc Res; 2020; 17(1):86-92. PubMed ID: 31957613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-16 attenuates β-amyloid-induced neurotoxicity through targeting β-site amyloid precursor protein-cleaving enzyme 1 in an Alzheimer's disease cell model.
    Zhong Z; Yuan K; Tong X; Hu J; Song Z; Zhang G; Fang X; Zhang W
    Neuroreport; 2018 Nov; 29(16):1365-1372. PubMed ID: 30142113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The long-non-coding RNA NEAT1 is a novel target for Alzheimer's disease progression via miR-124/BACE1 axis.
    Zhao MY; Wang GQ; Wang NN; Yu QY; Liu RL; Shi WQ
    Neurol Res; 2019 Jun; 41(6):489-497. PubMed ID: 31014193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of BACE1 degradation and APP processing by ubiquitin carboxyl-terminal hydrolase L1.
    Zhang M; Deng Y; Luo Y; Zhang S; Zou H; Cai F; Wada K; Song W
    J Neurochem; 2012 Mar; 120(6):1129-38. PubMed ID: 22212137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LRRTM3 promotes processing of amyloid-precursor protein by BACE1 and is a positional candidate gene for late-onset Alzheimer's disease.
    Majercak J; Ray WJ; Espeseth A; Simon A; Shi XP; Wolffe C; Getty K; Marine S; Stec E; Ferrer M; Strulovici B; Bartz S; Gates A; Xu M; Huang Q; Ma L; Shughrue P; Burchard J; Colussi D; Pietrak B; Kahana J; Beher D; Rosahl T; Shearman M; Hazuda D; Sachs AB; Koblan KS; Seabrook GR; Stone DJ
    Proc Natl Acad Sci U S A; 2006 Nov; 103(47):17967-72. PubMed ID: 17098871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.